Medical Communications
Eli Lilly partners with Ivy Tech Community College for scholarship programme
April 20, 2023 Medical Communications
Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …
ANGLE and BioView partner to develop a CTC-based HER2 assay
April 19, 2023 Medical Communications
ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …
FDA issues update around changes to COVID-19 vaccines’ EUAs
April 19, 2023 Medical Communications
The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …
Neuspera Medical receives FDA approval for peripheral nerve pain system
April 19, 2023 Medical Communications
Medical device company Neuspera Medical has announced that it has received FDA approval for its implantable system, used to treat …
GSK enters into £1.6bn deal to acquire Bellus Health
April 18, 2023 Medical Communications
UK-based GSK has announced its plans to acquire Bellus Health, a Canadian late-stage biopharmaceutical company which focuses on treatments for …
FDA approves expanded indication for AbbVie’s chronic migraine treatment
April 18, 2023 Medical Communications
US-based AbbVie has announced that the FDA has granted approval for the expanded indication of its preventative chronic migraine treatment …
Companies showcase innovative biotech at American Association for Cancer Research
April 17, 2023 Medical Communications
Leading companies in the biotechnology sector will showcase their latest innovations at the American Association for Cancer Research (AACR) meeting …
Complement Therapeutics gains €72m in Series A financing for novel therapeutics research
April 17, 2023 Medical Communications
Preclinical stage biotechnology company Complement Therapeutics (CTx) has announced the completion of its Series A financing round, led by Gimv, …
Kala Pharmaceuticals receives FDA Fast Track Designation for human MSC-S therapy
April 13, 2023 Medical Communications
Clinical-stage biopharmaceutical company Kala Pharmaceuticals has announced that the FDA has granted it Fast Track Designation for its human mesenchymal …
Liberal states begin stockpiling abortion medications following Texas court ruling
April 12, 2023 Medical Communications
Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following a Texas judge Matthew Kacsmaryk’s attempt …
Cognizant and Boehringer Ingelheim collaborate on integrated cloud platform to improve therapy development
April 12, 2023 Medical Communications
US-based Cognizant and biopharmaceutical company Boehringer Ingelheim have announced a partnership to collaborate on ensuring the quality, and increasing the …
FDA authorises marketing of MISHA Knee System for patients with knee osteoarthritis
April 11, 2023 Medical Communications
Medical device company, Moximed, has announced that the FDA granted marketing authorisation of its MISHA Knee System, an implantable shock …
AstraZeneca’s Lynparza approved by NHS England
April 6, 2023 Medical Communications
NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …
AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial
April 5, 2023 Medical Communications
AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …
FDA requires prepaid mail-back envelopes for opioid analgesics
April 5, 2023 Medical Communications
The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …
Latest content
October 26, 2026
